Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2016

Open Access 01-08-2016 | Bone and Soft Tissue Sarcomas

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma

Authors: Miriam L. Hoven-Gondrie, MD, PhD, Esther Bastiaannet, PhD, Vincent K.Y. Ho, MSc, Barbara L. van Leeuwen, MD, PhD, Gerrit-Jan Liefers, MD, PhD, Harald J. Hoekstra, MD, PhD, Albert J. H. Suurmeijer, MD, PhD

Published in: Annals of Surgical Oncology | Issue 8/2016

Login to get access

Abstract

Background

Nearly half of soft-tissue sarcoma (STS) patients are over the age of 65, and the behavior of cancer in these elderly patients is poorly understood. The aim of this study was to assess the impact of age, sarcoma histotype, grade, stage, and treatment modalities on survival of extremity STS (ESTS) patients.

Methods

Patients ≥18 years diagnosed with ESTS between 1989 and 2008 were selected from the Netherlands Cancer Registry. Survival rates and patient and treatment characteristics were analyzed for all patients. Relative survival and relative excess risk of death were estimated for young (<65 years) and older (>65 years) patients.

Results

Overall, 3066 patients were included in this study. Histotype was different between young (<65 years) and elderly (>65 years) patients (p < 0.001). Patients over the age of 65 were more often diagnosed with high-stage ESTS and an increasing proportion of high-grade ESTS (p < 0.001). The proportion of patients who received no treatment increased with age, and the elderly received fewer combined-modality treatments. Age was significantly associated with relative 5-year survival [72.7 % for younger patients and 43.8 % for the oldest elderly (>85 years)]. In multivariable analysis, age still remained a significant prognostic factor.

Conclusions

Different distribution of sarcoma histotypes, more high-stage and high-grade sarcomas at diagnosis, less aggressive treatment, and worse survival rates emphasize the need for optimizing sarcoma research and care of the elderly.
Appendix
Available only for authorised users
Literature
1.
WHO classification of tumours of soft tissue and bone. Lyon: IARC; 2013.
2.
3.
Nijhuis PH, Schaapveld M, Otter R, et al. Epidemiological aspects of soft tissue sarcomas (STS)—consequences for the design of clinical STS trials. Eur J Cancer. 1999;35:1705–10.CrossRefPubMed
4.
Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530–43.CrossRefPubMed
5.
ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, et al. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up. Ann Surg Oncol. 2007;14:222–9.CrossRefPubMed
6.
Pautier P, Genestie C, Rey A, et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer. 2000;88:1425–31.CrossRefPubMed
7.
Brooks AD, Bowne WB, Delgado R, et al. Soft tissue sarcomas of the groin: diagnosis, management, and prognosis. J Am Coll Surg. 2001;193:130–6.CrossRefPubMed
8.
Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–89.PubMed
9.
LeVay J, O’Sullivan B, Catton C, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys. 1993;27:1091–9.CrossRefPubMed
10.
Parsons HM, Habermann EB, Tuttle TM, et al. Conditional survival of extremity soft-tissue sarcoma: results beyond the staging system. Cancer. 2011;117:1055–60.CrossRefPubMed
11.
Fentiman IS, Tirelli U, Monfardini S, et al. Cancer in the elderly: why so badly treated? Lancet. 1990;335:1020–2.CrossRefPubMed
12.
13.
Nijhuis PH, Schaapveld M, Otter R, et al. Soft tissue sarcoma—compliance with guidelines. Cancer. 2001;91:2186–95.CrossRefPubMed
14.
Levi F, La Vecchia C, Randimbison L, et al. Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland. Eur J Cancer. 1999;35:1711–6.CrossRefPubMed
15.
Farshadpour F, Schaapveld M, Suurmeijer AJ, et al. Soft tissue sarcoma: why not treated? Crit Rev Oncol Hematol. 2005;54:77–83.CrossRefPubMed
16.
Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–7.CrossRefPubMed
17.
Hoekstra HJ, Thijssens K, van Ginkel RJ. Role of surgery as primary treatment and as intervention in the multidisciplinary treatment of soft tissue sarcoma. Ann Oncol. 2004;15(suppl 4):iv181–6.PubMed
18.
Thijssens KM, van Ginkel RJ, Pras E, et al. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Ann Surg Oncol. 2006;13:518–24.CrossRefPubMed
19.
Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.PubMed
20.
21.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th edition. New York: Springer; 2010.
22.
Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306–9.CrossRefPubMed
23.
Lahat G, Dhuka AR, Lahat S, et al. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009;16:2579–86.CrossRefPubMed
24.
Parsons JT, Zlotecki RA, Reddy KA, et al. The role of radiotherapy and limb-conserving surgery in the management of soft-tissue sarcomas in adults. Hematol Oncol Clin North Am. 2001;15:377–88.CrossRefPubMed
25.
Gutierrez JC, Perez EA, Franceschi D, et al. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res. 2007;141:105–14.CrossRefPubMed
26.
Biau DJ, Ferguson PC, Turcotte RE, et al. Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk. J Clin Oncol. 2011;29:4029–35.CrossRefPubMed
27.
Boden RA, Clark MA, Neuhaus SJ, et al. Surgical management of soft tissue sarcoma in patients over 80 years. Eur J Surg Oncol. 2006;32:1154–8.CrossRefPubMed
28.
Al-Refaie WB, Habermann EB, Dudeja V, et al. Extremity soft tissue sarcoma care in the elderly: insights into the generalizability of NCI Cancer Trials. Ann Surg Oncol. 2010;17:1732–8.CrossRefPubMed
29.
Marusyk A, DeGregori J. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations. Biochim Biophys Acta. 2008;1785:1–11.PubMed
30.
Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3:991–8.CrossRefPubMed
31.
Verweij J, Baker LH. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations. Eur J Cancer. 2010;46:863–8.CrossRefPubMed
32.
Wunder JS, Nielsen TO, Maki RG, et al. Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol. 2007;8:513–24.CrossRefPubMed
33.
34.
Mendenhall WM, Indelicato DJ, Scarborough MT, et al. The management of adult soft tissue sarcomas. Am J Clin Oncol. 2009;32:436–42.CrossRefPubMed
35.
Al-Refaie WB, Habermann EB, Jensen EH, et al. Surgery alone is adequate treatment for early stage soft tissue sarcoma of the extremity. Br J Surg. 2010;97:707–13.CrossRefPubMed
36.
Buchner M, Bernd L, Zahlten-Hinguranage A, et al. Primary malignant tumours of bone and soft tissue in the elderly. Eur J Surg Oncol. 2004;30:877–83.CrossRefPubMed
37.
Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev. 2005;31:380–402.CrossRefPubMed
38.
Moore J, Isler M, Barry J, et al. Major wound complication risk factors following soft tissue sarcoma resection. Eur J Surg Oncol. 2014;40:1671–6.CrossRefPubMed
39.
Horton JK, Gleason JF Jr, Klepin HD, et al. Age-related disparities in the use of radiotherapy for treatment of localized soft tissue sarcoma. Cancer. 2011;117:4033–40.CrossRefPubMedPubMedCentral
40.
Le Cesne A, Ouali M, Leahy MG, et al. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials. Ann Oncol. 2014;25:2425–32.CrossRefPubMed
41.
Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13:1045–54.CrossRefPubMed
42.
Chen H, Cantor A, Meyer J, et al. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer. 2003;97:1107–14.CrossRefPubMed
43.
Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;21:2719–25.CrossRefPubMed
44.
Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720–6.CrossRefPubMed
Metadata
Title
Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma
Authors
Miriam L. Hoven-Gondrie, MD, PhD
Esther Bastiaannet, PhD
Vincent K.Y. Ho, MSc
Barbara L. van Leeuwen, MD, PhD
Gerrit-Jan Liefers, MD, PhD
Harald J. Hoekstra, MD, PhD
Albert J. H. Suurmeijer, MD, PhD
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 8/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5158-7

Other articles of this Issue 8/2016

Annals of Surgical Oncology 8/2016 Go to the issue

Colorectal Cancer

Laparoscopic Radical Extended Right Hemicolectomy Using a Caudal-to-Cranial Approach

Healthcare Policy and Outcomes

Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes

Melanomas

SPECT/CT Improves Detection of Metastatic Sentinel Lymph Nodes in Patients with Head and Neck Melanoma

Colorectal Cancer

Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study

Melanomas

Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management

Endocrine Tumors

Family Screening in Familial Papillary Carcinoma: The Early Detection of Thyroid Disease